retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Retatrutide Retatrutide: The "Triple G" Peptide

With a half-life of approximately 5 days, tirzepatide takes 25 to 30 days to fully clear your system after the final injection

Phase 3 TRIUMPH-4: 28.7% at 68 weeks

GLP-1 agonists such as Wegovy (semaglutide) and Zepbound (tirzepatide) have demonstrated up to 20% body weight reductions in pivotal trials an efficacy previously thought achievable only through bariatric surgery

Nonetheless, established neurodegenerative diseases have a limited response, underscoring the need of prevention rather than therapy

At the highest maintenance dose of 2.4mg, that same vial provides barely 2 injections

The Medicines and Healthcare products Regulatory Agency said anyone experiencing side effects should talk to their doctor, pharmacist or nurse and report it directly to the Yellow Card scheme.